164 results on '"Forde, P. M."'
Search Results
2. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
3. Association between pathologic response and survival after neoadjuvant therapy in lung cancer
4. Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer
5. Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
6. GraphSNP: an interactive distance viewer for investigating outbreaks and transmission networks using a graph approach
7. Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis
8. First report of nerine yellow stripe virus in Clivia miniata in the United Kingdom
9. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
10. Persistent mutation burden drives sustained anti-tumor immune responses
11. Emergence and clonal expansion of a qacA-harbouring sequence type 45 lineage of methicillin-resistant Staphylococcus aureus
12. TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection
13. Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in Wales
14. Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors
15. Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
16. Advancing neoadjuvant immunotherapy for lung cancer
17. Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer
18. The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
19. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial
20. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board
21. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
22. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
23. The clinical presentation, treatment and outcome of serologically confirmed paediatric Lyme disease in the Republic of Ireland over a 5-year period: a retrospective cohort study
24. Outbreak of multi-drug-resistant (MDR) Shigella flexneri in northern Australia due to an endemic regional clone acquiring an IncFII plasmid
25. Detection and characterization of lung cancer using cell-free DNA fragmentomes
26. MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction
27. Comprehensive analysis of IncC plasmid conjugation identifies a crucial role for the transcriptional regulator AcaB
28. Epigenetic therapy inhibits metastases by disrupting premetastatic niches
29. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
30. Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis
31. Immunotherapy trials in mesothelioma — promising results, but don’t stop here
32. Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
33. Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei
34. Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection
35. SMRT sequencing reveals differential patterns of methylation in two O111:H- STEC isolates from a hemolytic uremic syndrome outbreak in Australia
36. Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
37. Use of Immune Checkpoint Inhibitors in Mesothelioma
38. Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
39. Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
40. Business Educators' Perceptions of the Impact of Their Professional Development on Classroom Instruction
41. The Survival of Professional Organizations: A New Thrust
42. University Administrators' Perceptions and Practices of Electronic Mail as a Communication Channel.
43. Business Educators' Awareness, Implementation, and Value of the National Standards for Business Education.
44. Systematic Study of the Oxidation of Methane Using Supported Gold Palladium Nanoparticles Under Mild Aqueous Conditions
45. Venous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers
46. Model-based analysis and optimization of bioreactor for hematopoietic stem cell cultivation
47. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials—Standardizing Eligibility Criteria
48. Development of a pilot-scale bacterial fermentation for plasmid-based biopharmaceutical production using a stoichiometric medium
49. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
50. First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.